WHO monographs on selected medicinal plants - travolekar.ru
WHO monographs on selected medicinal plants - travolekar.ru WHO monographs on selected medicinal plants - travolekar.ru
Radix Withaniae glycoprotein and acute phase protein were decreased to undetectable levels (16). Intragastric administration of the root, at doses of 500, 1000, 1500 or 1200 mg/kg bw, given orally as a suspension 3–4 hours prior to induction of inflammation, also caused a dose-dependent suppression of 2-macroglobulin (an indicator for anti-inflammatory drugs) in the serum of rats inflamed by subplantar injection of carrageenan. The maximum effect (about 75%) was seen at 1.0 g/kg bw. Actual measurements of inflammation were not made (16). Glycowithanolides and a mixture of sitoindosides IX and X isolated from the crude drug were evaluated for their immunomodulatory and central nervous system effects (antistress and improvements to memory and learning) in mice and rats. Both mixtures of compounds led to mobilization and activation of peritoneal macrophages, phagocytosis and increased activity of the lysosomal enzymes (16). Anti-ischaemic activity An in vivo study assessed the effect of the crude drug as a prophylactic treatment against stroke using the middle cerebral artery occlusion model in rats. Two groups of rats were pretreated with a hydroalcoholic extract of the crude drug (1.0 g/kg, administered by gastric lavage) for 15 or 30 days. The rats were then subjected to focal ischaemia by occlusion of the middle cerebral artery using an intraluminal thread. After 2 hours of middle cerebral artery occlusion, reperfusion was allowed by retracting the thread and the animals were assessed for ischaemic changes 30 min after reperfusion. Twenty-four hours later, rats were subjected to motor performance tests and were subsequently killed to enable estimation of the marker of oxidative stress, malondialdehyde. Significant motor impairment, with elevated levels of malondialdehyde, was observed in middle cerebral artery-occluded control rats. Treatment with the crude drug for 30 days prevented motor impairment and significantly decreased the raised levels of malondialdehyde compared with rats treated with the vehicle. Treatment also attenuated the percentage hemispheric lesion area in diffusion-weighted imaging (17 ± 2%) compared with the vehicle-treated middle cerebral artery-occluded group (30 ± 4%) (24). A study was conducted to evaluate the cardioprotective potential of a hydro-alcoholic extract of the roots, by assessing the effects of treatment on haemodynamic, histopathological and biochemical parameters in isoprenaline- (isoproterenol-) induced myocardial necrosis in rats and to compare the effects with those of vitamin E (25). Rats were divided into six main groups: sham, isoprenaline control, Withania somnifera and vitamin E controls and Withania somnifera and vitamin E treatment groups. The root extract was administered at doses of 25, 50 and 100 mg/kg, and 379
- Page 336 and 337: WHO monogr
- Page 338 and 339: WHO monogr
- Page 340 and 341: WHO monogr
- Page 342 and 343: WHO monogr
- Page 344 and 345: WHO monogr
- Page 346 and 347: WHO monogr
- Page 348 and 349: WHO monogr
- Page 350 and 351: WHO monogr
- Page 352 and 353: WHO monogr
- Page 354 and 355: WHO monogr
- Page 356 and 357: WHO monogr
- Page 358 and 359: WHO monogr
- Page 360 and 361: WHO monogr
- Page 362 and 363: WHO monogr
- Page 364 and 365: WHO monogr
- Page 366 and 367: WHO monogr
- Page 368 and 369: WHO monogr
- Page 370 and 371: WHO monogr
- Page 372 and 373: Cortex Viburni Prunifolii Definitio
- Page 374 and 375: WHO monogr
- Page 376 and 377: WHO monogr
- Page 378 and 379: WHO monogr
- Page 380 and 381: WHO monogr
- Page 382 and 383: WHO monogr
- Page 384 and 385: WHO monogr
- Page 388 and 389: WHO monogr
- Page 390 and 391: WHO monogr
- Page 392 and 393: WHO monogr
- Page 394 and 395: WHO monogr
- Page 396 and 397: WHO monogr
- Page 398 and 399: WHO monogr
- Page 400 and 401: Annex 1 Participants of the Fourth
- Page 402 and 403: WHO monogr
- Page 404 and 405: WHO monogr
- Page 406 and 407: WHO monogr
- Page 408 and 409: Annex 4 Cumulative index of medicin
- Page 410 and 411: WHO monogr
- Page 412 and 413: WHO monogr
- Page 414 and 415: Annex 5 Cumulative index of major c
- Page 416 and 417: WHO monogr
- Page 418 and 419: WHO monogr
- Page 420 and 421: WHO monogr
- Page 422 and 423: WHO monogr
- Page 424 and 425: WHO monogr
- Page 426 and 427: WHO monogr
- Page 428 and 429: WHO monogr
- Page 430 and 431: WHO monogr
- Page 432 and 433: WHO monogr
- Page 434 and 435: WHO monogr
Radix Withaniae<br />
glycoprotein and acute phase protein were decreased to undetectable<br />
levels (16).<br />
Intragastric administrati<strong>on</strong> of the root, at doses of 500, 1000, 1500 or<br />
1200 mg/kg bw, given orally as a suspensi<strong>on</strong> 3–4 hours prior to inducti<strong>on</strong><br />
of inflammati<strong>on</strong>, also caused a dose-dependent suppressi<strong>on</strong> of 2-macroglobulin<br />
(an indicator for anti-inflammatory d<strong>ru</strong>gs) in the se<strong>ru</strong>m of rats<br />
inflamed by subplantar injecti<strong>on</strong> of carrageenan. The maximum effect<br />
(about 75%) was seen at 1.0 g/kg bw. Actual measurements of inflammati<strong>on</strong><br />
were not made (16). Glycowithanolides and a mixture of sitoindosides<br />
IX and X isolated from the c<strong>ru</strong>de d<strong>ru</strong>g were evaluated for their immunomodulatory<br />
and central nervous system effects (antistress and<br />
improvements to memory and learning) in mice and rats. Both mixtures of<br />
compounds led to mobilizati<strong>on</strong> and activati<strong>on</strong> of perit<strong>on</strong>eal macrophages,<br />
phagocytosis and increased activity of the lysosomal enzymes (16).<br />
Anti-ischaemic activity<br />
An in vivo study assessed the effect of the c<strong>ru</strong>de d<strong>ru</strong>g as a prophylactic<br />
treatment against stroke using the middle cerebral artery occlusi<strong>on</strong> model<br />
in rats. Two groups of rats were pretreated with a hydroalcoholic extract<br />
of the c<strong>ru</strong>de d<strong>ru</strong>g (1.0 g/kg, administered by gastric lavage) for 15 or<br />
30 days. The rats were then subjected to focal ischaemia by occlusi<strong>on</strong> of<br />
the middle cerebral artery using an intraluminal thread. After 2 hours of<br />
middle cerebral artery occlusi<strong>on</strong>, reperfusi<strong>on</strong> was allowed by retracting<br />
the thread and the animals were assessed for ischaemic changes 30 min<br />
after reperfusi<strong>on</strong>. Twenty-four hours later, rats were subjected to motor<br />
performance tests and were subsequently killed to enable estimati<strong>on</strong> of<br />
the marker of oxidative stress, mal<strong>on</strong>dialdehyde. Significant motor impairment,<br />
with elevated levels of mal<strong>on</strong>dialdehyde, was observed in middle<br />
cerebral artery-occluded c<strong>on</strong>trol rats. Treatment with the c<strong>ru</strong>de d<strong>ru</strong>g<br />
for 30 days prevented motor impairment and significantly decreased the<br />
raised levels of mal<strong>on</strong>dialdehyde compared with rats treated with the<br />
vehicle. Treatment also attenuated the percentage hemispheric lesi<strong>on</strong> area in<br />
diffusi<strong>on</strong>-weighted imaging (17 ± 2%) compared with the vehicle-treated<br />
middle cerebral artery-occluded group (30 ± 4%) (24).<br />
A study was c<strong>on</strong>ducted to evaluate the cardioprotective potential of a<br />
hydro-alcoholic extract of the roots, by assessing the effects of treatment<br />
<strong>on</strong> haemodynamic, histopathological and biochemical parameters in isoprenaline-<br />
(isoproterenol-) induced myocardial necrosis in rats and to<br />
compare the effects with those of vitamin E (25). Rats were divided into<br />
six main groups: sham, isoprenaline c<strong>on</strong>trol, Withania somnifera and vitamin<br />
E c<strong>on</strong>trols and Withania somnifera and vitamin E treatment groups.<br />
The root extract was administered at doses of 25, 50 and 100 mg/kg, and<br />
379